Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Bienvenido G. Yangco"'
Autor:
Kate Buchacz, Rose Baker, Douglas J. Ward, Frank J. Palella, Joan S. Chmiel, Benjamin Young, Bienvenido G. Yangco, Richard M. Novak, John T. Brooks
Publikováno v:
AIDS Research and Treatment, Vol 2012 (2012)
Background. Little is known about temporal trends in frequencies of clinically relevant ARV resistance mutations in HIV strains from U.S. patients undergoing genotypic testing (GT) in routine HIV care. Methods. We analyzed cumulative frequency of HIV
Externí odkaz:
https://doaj.org/article/2679c23559a44e598f0a1751cb354062
Autor:
Kate Buchacz, Douglas J. Ward, Richard M. Novak, Ellen Tedaldi, Bienvenido G. Yangco, Hiv Outpatient Study, Carl Armon, Frank J. Palella, Rachel Hart, Linda Battalora, Jun Li
Publikováno v:
AIDS. 33:2327-2335
To understand the epidemiology of non-AIDS-related chronic comorbidities (NACMs) among aging persons with HIV (PWH).Prospective multicenter observational study to assess, in an age-stratified fashion, number and types of NACMs by demographic and HIV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2d3ed79f939d4fe71c00bab76135c1c
https://doi.org/10.1097/qad.0000000000002349
https://doi.org/10.1097/qad.0000000000002349
Autor:
Xiaohong Hu, Jacek Skarbinski, Dana Franklin, Rachel Hart, Carl Armon, Frank J. Palella, Kathy Wood, Emma L. Frazier, H. Irene Hall, Kate Buchacz, Ping Huang, John T. Brooks, Bienvenido G. Yangco, Joan S. Chmiel, Richard M. Novak
Publikováno v:
The Open AIDS Journal
Comparative analyses of the characteristics of persons living with HIV infection (PLWH) in the United States (US) captured in surveillance and other observational databases are few. To explore potential joint data use to guide HIV treatment and preve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::debb07017f3dc022397089d7dfb431d3
http://europepmc.org/articles/PMC4714382
http://europepmc.org/articles/PMC4714382
Autor:
Bonnie Dean, Frank J. Palella, John Hammer, Doug Ward, Rachel Hart, John T. Brooks, Benjamin Young, Kathleen C. Wood, Marcus D. Durham, Jerian Denise Dixon-Evans, Dania Beadle, Dana Franklin, Bienvenido G. Yangco, Richard M. Novak, Kate Buchacz, Jane Esteves, Conor Daniel Flaherty, Ellen Tedaldi, Jack Fuhrer, Cheryl Stewart, Faye Ruley, Ramona A. Christian, Thilakavathy Subramanian, Mia Scott, Kenneth S. Greenberg, Princess Graham, Darlene Hankerson, Linda Ording-Bauer, Kalliope Chagaris, Rita Kelly, Kenneth A. Lichtenstein, Rosa Franklin, Andrea Wendrow, Carl Armon, Renata Smith, Barbara Widick, Joan S. Chmiel, Saira Jahangir, Harlen Hays
Publikováno v:
Journal of Antimicrobial Chemotherapy. 70:2337-2346
BackgroundMonitoring antiretroviral drug resistance can inform treatment recommendations; however, there are few such data from US patients before they initiate ART.MethodsWe analysed data from HIV Outpatient Study (HOPS) participants from nine US HI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::874c32d64ad4355bc009ecd44e9635af
https://doi.org/10.1093/jac/dkv120
https://doi.org/10.1093/jac/dkv120
Autor:
Bienvenido G, Yangco, Kate, Buchacz, Rose, Baker, Frank J, Palella, Carl, Armon, John T, Brooks, Joslyn, Axinn
Publikováno v:
AIDS Patient Care and STDs. 28:280-283
We analyzed 369 patients with no prior Mycobacterium avium complex (MAC) infection and CD4 < 50 cells/ μL (baseline), while on combination antiretroviral therapy(cART), for incidence rates of primary MAC infection during the 6 months after baseline,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17ce3018d04bdbed41df6322d77bcb0e
https://doi.org/10.1089/apc.2013.0270
https://doi.org/10.1089/apc.2013.0270
Autor:
C. Armon, Nabil Rayeed, Joan S. Chmiel, J. S. Chmiel, Saira Jahangir, Troy Thomas, Kate Buchacz, M. Durham, R. Hart, John A. Hammer, Thilakavathy Subramanian, Richard M. Novak, Conor Daniel Flaherty, Genevieve Looby, Barbara Widick, Carl Armon, J. T. Brooks, Kathy Wood, Bienvenido G. Yangco, Kalliope Chagaris, John T. Brooks, Stacey Purinton, Ramona A. Christian, B. Dean, Mia Scott, Cheryl Stewart, Doug Ward, Dana Franklin, Rosa Franklin, Princess Davenport, Faye Ruley, B. Yangco, Benjamin Young, Dania Beadle, Harlen Hays, Marcus D. Durham, Rachel Hart, Andrea Wendrow, Rita Kelly, Ellen Tedaldi, Linda Ording-Bauer, Jane Esteves, Frank J. Palella, Jack Fuhrer, Kenneth S. Greenberg, Cheryl Akridge, Kenneth A. Lichtenstein
Publikováno v:
The Journal of antimicrobial chemotherapy. 71(9)
Objectives We sought to evaluate associations between CD4 at ART initiation (AI), achieving CD4 >750 cells/mm3 (CD4 >750), long-term immunological recovery and survival. Methods This was a prospective observational cohort study. We analysed data from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa479fc29e5d9100167b0ca1ee1787ad
https://pubmed.ncbi.nlm.nih.gov/27330061
https://pubmed.ncbi.nlm.nih.gov/27330061
Autor:
Frank J. Palella, John T. Brooks, Jane Esteves, Jack Fuhrer, Kathleen C. Wood, Ramona A. Christian, Kate Buchacz, Linda Ording-Bauer, Kenneth A. Lichtenstein, Joan S. Chmiel, Andrea Wendrow, Pragna Patel, Harlen Hays, Troy Thomas, Bonnie Dean, Cheryl Stewart, Faye Ruley, Barbara Widick, Conor Daniel Flaherty, Benjamin Young, Doug Ward, Marcus D. Durham, R. Debes, Renata Smith, Richard M. Novak, Princess Graham, Kalliope Chagaris, Rosa Franklin, Kenneth S. Greenberg, John Hammer, Darlene Hankerson, Dania Beadle, Ellen Tedaldi, Carl Armon, Kathy Wood, Saira Jahangir, Rita Kelly, Thilakavathy Subramanian, Jerian Denise Dixon-Evans, Bienvenido G. Yangco, Patricia Avery, Mia Scott
Publikováno v:
Clin Infect Dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9e339165288b39a5bab613ebb7ddc64
https://pubmed.ncbi.nlm.nih.gov/25501987
https://pubmed.ncbi.nlm.nih.gov/25501987
Short‐Term Safety and Antiretroviral Activity of T‐1249, a Second‐Generation Fusion Inhibitor of HIV
Autor:
Pam Rusnak, Adriann Diers, Rebecca Spence, Claude Drobnes, John Bartlett, Thomas E. Melby, Roberto C. Arduino, Ralph DeMasi, Roy M. Gulick, Joseph J. Eron, J. Michael Kilby, Bienvenido G. Yangco, G. Diego Miralles, Claire Raskino, Thomas C. Merigan, Ying Zhang, Michael E. Greenberg
Publikováno v:
The Journal of Infectious Diseases. 189:1075-1083
T-1249 is a 39-aa synthetic peptide that inhibits fusion of human immunodeficiency virus (HIV) to the host target cell. A 14-day open-label, phase 1/2 dose-escalation monotherapy study of the safety and antiretroviral activity of T-1249 was performed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84965959f0272605da11d161955be936
https://doi.org/10.1086/381707
https://doi.org/10.1086/381707
Autor:
Felix Carpio, Harold W. Horowitz, Eugene Sun, Harold A. Kessler, Barry Bernstein, Richard Bertz, Bienvenido G. Yangco, Judith Feinberg, Joseph J. Eron, David Wheeler, Donna Mildvan, Peter Ruane, Martin S. King, Mallory D. Witt
Publikováno v:
The Journal of Infectious Diseases. 189:265-272
The safety, pharmacokinetics, and antiviral activity of lopinavir, a human immunodeficiency virus (HIV) protease inhibitor, coformulated with ritonavir as a pharmacokinetic enhancer were evaluated in 38 antiretroviral-naive patients randomized 1:1 to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a66bd5fc90bb0f6902a720311157066
https://doi.org/10.1086/380799
https://doi.org/10.1086/380799
Autor:
William J. Holloway, David H. Henry, Roberta Luskin-Hawk, Gale Smith, Naomi E. Aronson, Robert R. Redfleld, Robert L Yarrish, Bienvenido G. Yangco, Deborah L. Birx, Charles Davis, Karl V. Sitz, Thomas M. Kerkering, Phil Renzullo, John G. McNeil, Lawrence Deyton, Edmond Tramont, Carol O. Tacket, Fred M. Gordin, Robin P. Garner, Donald M. Poretz, Nelson L. Michael, Melanie A. Thompson, Lawrence D. Loomis-Price, John F. Brundage, Nancy Ruiz, Phillip F. Pierce, Silvia Ratto-Kim
Publikováno v:
The Journal of Infectious Diseases. 181:881-889
A phase II efficacy trial was conducted with recombinant human immunodeficiency virus (HIV) type 1 envelope glycoprotein gp160 (rgp160) in 608 HIV-infected, asymptomatic volunteers with CD4+ cell counts >400 cells/mm3. During a 5-year study, voluntee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1194827c7dafb7bfb3854bf7681fc30
https://doi.org/10.1086/315308
https://doi.org/10.1086/315308